Pfizer ups drug prices

Share this article:
Industry analysts say average wholesale prices for Pfizer drugs such as Lipitor and Celebrex went up by more than 5%, Reuters reported. A Bear Stearns analyst quoted in the report said the price hike, effective Jan. 1, was somewhat more aggressive than price increases taken in each of the previous three years. He estimated the rise at 5.2%; a Merrill Lynch analyst pegged it at 5.6%. While cholesterol drug Lipitor and arthritis therapy Celebrex were included in the increase, newer drugs Chantix (smoking cessation) and Exubera (diabetes) were not. The 5% boost surprised some analysts, who said they had anticipated a lesser increase in light of political scrutiny over drug pricing expected this year. However, one analyst added, Pfizer may have raised prices sharply to make good on its prediction that 2007 revenue will match that seen last year.
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.